| http://purl.uniprot.org/citations/21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/21596874 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundAn influence of polymorphic cytochromes P450 (CYP) 2D6 genetic variants on antiemetic efficacy of ondansetron has been suggested. However, the role of CYP3A in ondansetron metabolism and efficacy has been unclear. In this study, we evaluated the hypothesis that genotype-dependent CYP2D6 and CYP3A activity selectively influences plasma concentrations of ondansetron enantiomers. Additionally, the effects of doubling the ondansetron dose on genotype-dependent plasma concentrations were investigated.MethodsPatients received IV ondansetron 4 or 8 mg for emesis prophylaxis before emergence from anesthesia. The CYP2D6-dependent activity score representing no, decreased, normal, or increased CYP2D6 enzyme activity as well as CYP3A low (CYP3A5*3/*3) and high expressor status (CYP3A5 wt/wt or wt/*3) were determined. Plasma concentrations of R- and S-ondansetron enantiomers were measured by liquid chromatography-tandem mass spectrometry. Area under the plasma concentration-time curves (AUCs) of R- and S-ondansetron were associated with CYP2D6 and CYP3A5 genotype-dependent enzyme activity.ResultsComplete data of 141 subjects were analyzed. Concentrations of S-ondansetron differed between CYP2D6 activity groups (P = 0.01) with highest values in patients with no CYP2D6 activity (mean [95% confidence interval]: 362.5 [238.3/486.7] h · ng/mL) and lowest values in those with increased activity (149.6 [114.5/184.8] h · ng/mL) compared with subjects displaying genotypes resulting in reduced or normal CYP2D6 activity (263.6 [228.8/298.8], 255.4 [228.2/282.7] h · ng/mL). AUC of R-ondansetron was 2 times higher in CYP3A5 low expressors compared with high expressors (281.5 [248.6/314.3] vs 142.5 [92.4/192.7] h · ng/mL; P = 0.003). Doubling the ondansetron dose increased plasma concentrations only in individuals with low CYP3A activity, but not in individuals with high enzyme activity (P < 0.001).ConclusionsThe metabolism of ondansetron seems to be enantioselective. In this postoperative setting, CYP2D6 activity scores correlated with concentrations of S-ondansetron, whereas CYP3A5 expressor status mainly influenced concentrations of R-ondansetron. Genetically and environmentally determined CYP2D6 and CYP3A enzyme activity might have implications for antiemetic efficacy."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.org/dc/terms/identifier | "doi:10.1213/ane.0b013e31821d01bc"xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Zhang L."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Fimmers R."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Lee E.H."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Stuber F."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Stamer U.M."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Musshoff F."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Kleine-Brueggeney M."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/author | "Rauers N.I."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/date | "2011"xsd:gYear |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/name | "Anesth Analg"xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/pages | "48-54"xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/title | "CYP2D6- and CYP3A-dependent enantioselective plasma concentrations of ondansetron in postanesthesia care."xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://purl.uniprot.org/core/volume | "113"xsd:string |
| http://purl.uniprot.org/citations/21596874 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/21596874 |
| http://purl.uniprot.org/citations/21596874 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/21596874 |
| http://purl.uniprot.org/uniprot/#_A0A0F7KYR9-mappedCitation-21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/21596874 |
| http://purl.uniprot.org/uniprot/#_A0A0F7KZW3-mappedCitation-21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/21596874 |
| http://purl.uniprot.org/uniprot/#_A0A0F7L0X4-mappedCitation-21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/21596874 |
| http://purl.uniprot.org/uniprot/#_A0A2L1K0H8-mappedCitation-21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/21596874 |
| http://purl.uniprot.org/uniprot/#_D5KMQ2-mappedCitation-21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/21596874 |
| http://purl.uniprot.org/uniprot/#_D5KN50-mappedCitation-21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/21596874 |
| http://purl.uniprot.org/uniprot/#_D5KN61-mappedCitation-21596874 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/21596874 |